Publication | Closed Access

Rosuvastatin, Identified From a Zebrafish Chemical Genetic Screen for Antiangiogenic Compounds, Suppresses the Growth of Prostate Cancer

Oncogenic AgentMedicineAntiangiogenic CompoundsPathologyAnti-cancer AgentProstatic DiseasePharmacologyCancer GrowthCancer Research